Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
Rang in Aktien #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Aktienkurs
$1.04
Marktkapitalisierung
$603.62M
Veränderung (1 Tag)
-2.52%
Veränderung (1 Jahr)
-38.05%
Land
CN
Handel MicroPort NeuroTech Limited (2172)

Kategorie

Dividendenrendite-Verlauf für MicroPort NeuroTech Limited (2172)
Dividendenrendite (TTM) von MicroPort NeuroTech Limited (Aktienkürzel: 2172) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für MicroPort NeuroTech Limited (2172) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber